Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int J Mol Sci ; 22(24)2021 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-34948000

RESUMO

Cutaneous squamous cell carcinoma (cSCC) accounts for 25% of cutaneous malignancies diagnosed in Caucasian populations. Surgical removal in combination with radiation and chemotherapy are effective treatments for cSCC. Nevertheless, the aggressive metastatic forms of cSCC still have a relatively poor patient outcome. Studies have linked actin cytoskeletal dynamics and the Wnt/ß-catenin signaling pathway as important modulators of cSCC pathogenesis. Previous studies have also shown that the actin-remodeling protein Flightless (Flii) is a negative regulator of cSCC. The aim of this study was to investigate if the functional effects of Flii on cSCC involve the Wnt/ß-catenin signaling pathway. Flii knockdown was performed using siRNA in a human late stage aggressive metastatic cSCC cell line (MET-1) alongside analysis of Flii genetic murine models of 3-methylcholanthrene induced cSCC. Flii was increased in a MET-1 cSCC cell line and reducing Flii expression led to fewer PCNA positive cells and a concomitant reduction in cellular proliferation and symmetrical division. Knockdown of Flii led to decreased ß-catenin and a decrease in the expression of the downstream effector of ß-catenin signaling protein SOX9. 3-Methylcholanthrene (MCA)-induced cSCC in Flii overexpressing mice showed increased markers of cancer metastasis including talin and keratin-14 and a significant increase in SOX9 alongside a reduction in Flii associated protein (Flap-1). Taken together, this study demonstrates a role for Flii in regulating proteins involved in cSCC proliferation and tumor progression and suggests a potential role for Flii in aggressive metastatic cSCC.


Assuntos
Carcinoma de Células Escamosas/genética , Proteínas dos Microfilamentos/genética , Neoplasias Cutâneas/genética , Transativadores/genética , Regulação para Cima , Via de Sinalização Wnt , Animais , Carcinoma de Células Escamosas/induzido quimicamente , Linhagem Celular Tumoral , Proliferação de Células , Modelos Animais de Doenças , Feminino , Regulação Neoplásica da Expressão Gênica , Técnicas de Silenciamento de Genes , Humanos , Metilcolantreno/efeitos adversos , Camundongos , Neoplasias Cutâneas/induzido quimicamente
2.
Oncogene ; 40(46): 6456-6468, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34608264

RESUMO

Cancer metastasis accounts for nearly 90% of all cancer deaths. Metastatic cancer progression requires both cancer cell migration to the site of the metastasis and subsequent proliferation after colonization. However, it has long been recognized that cancer cell migration and proliferation can be uncoupled; but the mechanism underlying this paradox is not well understood. Here we report that TNFAIP8 (tumor necrosis factor-α-induced protein 8), a "professional" transfer protein of phosphoinositide second messengers, promotes cancer cell migration or metastasis but inhibits its proliferation or cancer growth. TNFAIP8-deficient mice developed larger tumors, but TNFAIP8-deficient tumor cells completely lost their ability to migrate toward chemoattractants and were defective in colonizing lung tissues as compared to wild-type counterparts. Mechanistically, TNFAIP8 served as a cellular "pilot" of tumor cell migration by locally amplifying PI3K-AKT and Rac signals on the cell membrane facing chemoattractant; at the same time, TNFAIP8 also acted as a global inhibitor of tumor cell growth and proliferation by regulating Hippo signaling pathway. These findings help explain the migration-proliferation paradox of cancer cells that characterizes many cancers.


Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Fibrossarcoma/patologia , Neoplasias Pulmonares/patologia , Neoplasias Cutâneas/patologia , Animais , Proteínas Reguladoras de Apoptose/genética , Linhagem Celular Tumoral , Movimento Celular , Proliferação de Células , Dietilnitrosamina/efeitos adversos , Feminino , Fibrossarcoma/induzido quimicamente , Fibrossarcoma/genética , Fibrossarcoma/metabolismo , Regulação Neoplásica da Expressão Gênica , Via de Sinalização Hippo , Humanos , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/metabolismo , Masculino , Metilcolantreno/efeitos adversos , Camundongos , Fosfatidilinositol 3-Quinases/metabolismo , Neoplasias Cutâneas/induzido quimicamente , Neoplasias Cutâneas/genética , Neoplasias Cutâneas/metabolismo
3.
Sci Rep ; 9(1): 4606, 2019 03 14.
Artigo em Inglês | MEDLINE | ID: mdl-30872677

RESUMO

The therapeutic effects of simvastatin for renal cell carcinoma (RCC) are controversial. In this study, the effects of simvastatin on the carcinogenic properties of 3-methylcholanthrene (3MC; an aryl-hydrocarbon receptor [AhR] agonist) in human renal epithelial cells (hRECs) were investigated. We exposed in vitro and in vivo models to 3MC to induce RCC onset. 3MC upregulated the epithelial-mesenchymal transition (EMT) and tumor biomarkers; the models exhibited the reciprocal expression of histone deacetylase 1 (HDAC1) and RhoA, namely increased HDAC1 and decreased RhoA expression, through hypoxia-inducible-factor (HIF)- and AhR-dependent mechanisms. In addition to inducing EMT biomarkers, 3MC decreased von Hippel-Lindau protein levels (a risk factor for RCC) and increased CD44 expression in hRECs, which were reversed by digoxin (a HIF inhibitor) and HDAC inhibitors (suberoylanilide hydroxamic acid and trichostatin A [TSA]). Simvastatin abolished the detrimental effects of 3MC by reducing HDAC1 expression, with resulting RhoA upregulation, and reactivating RhoA in vitro and in vivo. Notably, the protective effects of simvastatin were negated by an HDAC activator (ITSA) through TSA suppression. The crucial role of RhoA in RCC carcinogenesis was verified by the overexpression of constitutively active RhoA. Collectively, these results demonstrate that simvastatin restores RhoA function through HDAC1 inhibition; therefore, simvastatin might serve as adjunct therapy for RCC induced by 3MC.


Assuntos
Células Epiteliais/efeitos dos fármacos , Histona Desacetilase 1/antagonistas & inibidores , Inibidores de Histona Desacetilases/farmacologia , Rim/efeitos dos fármacos , Metilcolantreno/efeitos adversos , Sinvastatina/farmacologia , Proteína rhoA de Ligação ao GTP/metabolismo , Carcinogênese/induzido quimicamente , Carcinogênese/efeitos dos fármacos , Células Cultivadas , Células Epiteliais/metabolismo , Transição Epitelial-Mesenquimal/efeitos dos fármacos , Humanos , Receptores de Hialuronatos/metabolismo , Ácidos Hidroxâmicos/farmacologia , Rim/metabolismo , Receptores de Hidrocarboneto Arílico/metabolismo
4.
Mol Carcinog ; 55(2): 161-9, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25594762

RESUMO

The functional role of nuclear factor of activated T-cells (NFAT), while it has been extensively investigated in the immune system, remains uncertain in bladder cancer development. We here aim to assess the effects of cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressants known to specifically inactivate the NFAT pathway in immune cells, on neoplastic transformation of urothelial cells. Immunohistochemistry revealed that the expression levels of NFATc1, a NFAT isoform shown to function as an oncogene in a sarcoma model, were elevated in urothelial neoplasms, compared with non-neoplastic urothelial tissues, and in low-grade and high-grade papillary urothelial carcinomas, compared with papillary urothelial neoplasms of low malignant potential. In an immortalized normal urothelial cell line SVHUC, CsA and FK506 reduced NFATc1 expression, NFAT transcriptional activity, and the expression of c-myc, a downstream target of NFATc1 signals. Treatment with CsA or FK506 in the SVHUC cells undergoing neoplastic transformation induced by exposure to a chemical carcinogen 3-methylcholanthrene resulted in strong inhibition in colony formation in vitro as well as tumor formation in NOD-SCID mice. CsA and FK506 were additionally found to up-regulate the expression of several molecules that play a protective role in bladder tumorigenesis, including p53, p21, and p27, and down-regulate that of oncogenic genes, such as cyclin D1, cyclin D3, and cyclin E, in SVHUC cells with the carcinogen challenge. Thus, CsA and FK506 likely inhibit urothelial tumorigenesis. These findings offer a potential chemopreventive approach for urothelial tumors using NFAT inhibitors.


Assuntos
Transformação Celular Neoplásica/efeitos dos fármacos , Ciclosporina/administração & dosagem , Fatores de Transcrição NFATC/metabolismo , Tacrolimo/administração & dosagem , Neoplasias da Bexiga Urinária/tratamento farmacológico , Animais , Linhagem Celular , Ciclosporina/farmacologia , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Metilcolantreno/efeitos adversos , Camundongos , Camundongos Endogâmicos NOD , Camundongos SCID , Transdução de Sinais/efeitos dos fármacos , Tacrolimo/farmacologia , Neoplasias da Bexiga Urinária/metabolismo , Ensaios Antitumorais Modelo de Xenoenxerto
5.
PLoS One ; 10(6): e0129786, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26076008

RESUMO

Reactive oxygen species (ROS) produced by the inducible NADPH oxidase type 2 (NOX2) complex are essential for clearing certain infectious organisms but may also have a role in regulating inflammation and immune response. For example, ROS is involved in myeloid derived suppressor cell (MDSC)- and regulatory T cell (T(reg)) mediated T- and NK-cell suppression. However, abundant ROS produced within the tumor microenvironment, or by the tumor itself may also yield oxidative stress, which can blunt anti-tumor immune responses as well as eventually leading to tumor toxicity. In this study we aimed to decipher the role of NOX2-derived ROS in a chemically (by methylcholanthrene (MCA)) induced sarcoma model. Superoxide production by NOX2 requires the p47(phox) (NCF1) subunit to organize the formation of the NOX2 complex on the cell membrane. Homozygous mutant mice (NCF1*/*) have a functional loss of their super oxide burst while heterozygous mice (NCF1*/+) retain this key function. Mice harboring either a homo- or a heterozygous mutation were injected intramuscularly with MCA to induce sarcoma formation. We found that NOX2 functionality does not determine tumor incidence in the tested MCA model. Comprehensive immune monitoring in tumor bearing mice showed that infiltrating immune cells experienced an increase in their oxidative state regardless of the NOX2 functionality. While MCA-induced sarcomas where characterized by a T(reg) and MDSC accumulation, no significant differences could be found between NCF1*/* and NCF1*/+ mice. Furthermore, infiltrating T cells showed an increase in effector-memory cell phenotype markers in both NCF1*/* and NCF1*/+ mice. Tumors established from both NCF1*/* and NCF1*/+ mice were tested for their in vitro proliferative capacity as well as their resistance to cisplatin and radiation therapy, with no differences being recorded. Overall our findings indicate that NOX2 activity does not play a key role in tumor development or immune cell infiltration in the chemically induced MCA sarcoma model.


Assuntos
Transformação Celular Neoplásica , Glicoproteínas de Membrana/metabolismo , Metilcolantreno/efeitos adversos , NADPH Oxidases/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Sarcoma/etiologia , Sarcoma/metabolismo , Animais , Relação CD4-CD8 , Transformação Celular Neoplásica/induzido quimicamente , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/imunologia , Transformação Celular Neoplásica/metabolismo , Modelos Animais de Doenças , Memória Imunológica , Imunomodulação , Ativação Linfocitária/imunologia , Linfócitos do Interstício Tumoral/imunologia , Linfócitos do Interstício Tumoral/metabolismo , Camundongos , Camundongos Knockout , Mutação , NADPH Oxidase 2 , NADPH Oxidases/genética , Oxirredução , Sarcoma/patologia , Sarcoma/terapia , Carga Tumoral
6.
Int J Food Sci Nutr ; 66(3): 300-7, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25582180

RESUMO

Polycyclic aromatic hydrocarbons (PAHs) and halogenated aromatic hydrocarbons (HAHs) develop various adverse effects through activation of an aryl hydrocarbon receptor (AhR). The suppressive effects of brewed green tea and black tea on 3-methylcholanthrene (MC)-induced AhR activation and its downstream events were examined in the liver of rats. Ad-libitum drinking of green tea and black tea suppressed MC-induced AhR activation and elevation of ethoxyresorufin O-deethylase activity in the liver, whereas the teas themselves did not induce them. Tea showed a suppressive fashion on the expression of cytochrome P450 1A1 (CYP1A1). Tea suppressed the AhR activation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) ex vivo. A part of catechins and theaflavins was present in plasma and liver as conjugated and intact forms. The results of this study suggested that active component(s) of tea are incorporated in the liver and suppress the activity of CYP1As through the AhR activation pathway.


Assuntos
Camellia sinensis/química , Catequina/farmacologia , Citocromo P-450 CYP1A1/metabolismo , Fígado/efeitos dos fármacos , Metilcolantreno/efeitos adversos , Dibenzodioxinas Policloradas/efeitos adversos , Receptores de Hidrocarboneto Arílico/metabolismo , Animais , Biflavonoides/metabolismo , Biflavonoides/farmacologia , Catequina/metabolismo , Poluentes Ambientais/efeitos adversos , Hidrocarbonetos Halogenados/efeitos adversos , Fígado/metabolismo , Extratos Vegetais/farmacologia , Hidrocarbonetos Policíclicos Aromáticos/efeitos adversos , Ratos , Transdução de Sinais , Chá/química
7.
J Environ Pathol Toxicol Oncol ; 31(2): 109-19, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23216636

RESUMO

This work reports the chemopreventive property of hydroalcoholic extract of the Trichosanthes dioica root (TDA) against 3-methylcholanthrene (3-MC)-induced carcinogenesis in Swiss albino mice. TDA was administered orally at 2 and 4 mg/kg for 45 days after 24 hours of a single subcutaneous administration of 3-MC (200 µg) in mice. The mice were observed for 15 weeks to record tumor incidence (fibrosarcoma) and survival. After 15 weeks the mice were killed for the evaluation of hematological profiles and hepatic biochemical parameters viz lipid peroxidation, reduced glutathione, glutathione-S-transferase, superoxide dismutase, and catalase. TDA treatment markedly reduced tumor incidence and prolonged the life span of sarcoma-bearing mice compared with 3-MC control mice. Hematological profiles of TDA-treated mice were restored significantly to normal levels. TDA treatment significantly modulated the liver biochemical parameters compared with 3-MC control. Therefore, TDA possesses remarkable cancer chemopreventive efficacy plausibly mediated by multiple mechanisms in Swiss albino mice.


Assuntos
Fibrossarcoma/induzido quimicamente , Fibrossarcoma/prevenção & controle , Neoplasias Hepáticas/induzido quimicamente , Neoplasias Hepáticas/prevenção & controle , Metilcolantreno/efeitos adversos , Extratos Vegetais/uso terapêutico , Raízes de Plantas , Trichosanthes , Animais , Catalase/metabolismo , Quimioprevenção/métodos , Modelos Animais de Doenças , Fibrossarcoma/metabolismo , Glutationa/metabolismo , Glutationa Transferase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Neoplasias Hepáticas/metabolismo , Masculino , Camundongos , Fitoterapia/métodos , Extratos Vegetais/farmacologia , Superóxido Dismutase/metabolismo , Resultado do Tratamento
8.
J Pharmacol Exp Ther ; 342(1): 9-14, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22514335

RESUMO

A pathway of research is described, leading from the finding of an inhibitory effect of 3-methylcholanthrene on the carcinogenicity of an aminoazo dye, to the induction of drug-metabolizing enzymes by 3-methylcholanthrene, benzo[a]pyrene, and other polycyclic aromatic hydrocarbons, to the demonstration of enhanced drug metabolism in cigarette smokers, coffee drinkers, and people who eat charcoal-broiled beef. The results of these studies indicate that cigarette smoking, coffee drinking, and the ingestion of charcoal-broiled beef (all resulting in exposure to polycyclic aromatic hydrocarbons) can influence the dosing regimen needed for proper drug therapy and are potential confounders of clinical trials with drugs metabolized by polycyclic aromatic hydrocarbon-inducible enzymes.


Assuntos
Carvão Vegetal/metabolismo , Café , Interações Alimento-Droga , Preparações Farmacêuticas/metabolismo , Fumar/metabolismo , Animais , Benzo(a)pireno/efeitos adversos , Ensaios Clínicos como Assunto , Humanos , Inativação Metabólica , Masculino , Carne/efeitos adversos , Metilcolantreno/efeitos adversos , Camundongos , Farmacocinética , Hidrocarbonetos Policíclicos Aromáticos/efeitos adversos , Ratos , Fumar/efeitos adversos
9.
Medicina (B.Aires) ; 67(1): 44-48, jan.-fev. 2007. graf
Artigo em Espanhol | LILACS | ID: lil-464743

RESUMO

Aunque existen vacunas para prevenir la aparición de tumores en animales de experimentación, la mayoría de los intentos por aplicar aquellas vacunas con fines terapéuticos contra tumores establecidos no han sido exitosos. Para comprender la naturaleza de esta refractariedad, estudiamos un tumor de ratón fuertemente inmunogénico inducido por el carcinógeno químico metilcolantreno. En nuestro modelo, el inicio de esta refractariedad coincidió con el comienzo de un estado de inmunosupresión conocido como "eclipse inmunológico" caracterizado por una pérdida o bloqueo de la respuesta inmune antitumoral después que el tumor ha superado cierto tamaño crítico. Este eclipse inmunológico fue acompañado por un proceso de inflamación sistémica en el organismo. El tratamiento de los ratones portadores de tumor con una única dosis del corticoide sintético dexametasona (DX) redujo los parámetros de inflamación sistémica e indujo la reversión del eclipse. Esta reversión no fue por sí misma curativa pero permitió que un tratamiento inmunológico basado en células dendríticas estimuladas con antígenos tumorales, que por sí solo era absolutamente ineficaz, pudiera ejercer un significativo efecto inhibidor sobre un tumor en crecimiento. El esquema de dos pasos que comprende, primero, un tratamiento antiinflamatorio para revertir el eclipse y segundo, una estrategia de vacunación basada en células dendríticas destinada a estimular la respuesta inmune antitumoral, podría servir, eventualmente, como un modelo de inmunoterapia contra tumores en animales y seres humanos.


Although animals can be prophylactically immunized against the growth of tumor implants, most of the attempts to use immunotherapy to cause the regression of animal and human tumors once they become established have been unsuccessful. To understand the nature of this refractoriness we have studied a methylcholanthrene-induced and strongly immunogenic murine fibrosarcoma. In our model, the onset of this refractoriness was associated with the beginning of an immunosuppressive state known as "immunological eclipse" characterized by a loss of the antitumor immune response when tumor grows beyond a critical size. This immunological eclipse was accompanied by the emergence of a systemic inflammatory condition. Treatment of tumor-bearing mice with a single dose of a synthetic corticosteroid, dexamethasone (DX), reduced significantly all parameters of systemic inflammation and simultaneously reversed the immunological eclipse. The reversion of the eclipse upon DX treatment was not curative itself, but allowed an immunological therapy based in dendritic cells pulsed with tumor antigens, which was itself absolutely ineffective, to exert a significant inhibitory effect against an established growing tumor. The two-step schedule using an anti-inflammatory treatment to reverse the immunological eclipse plus a dendritic cell-based vaccination strategy aimed to stimulate the anti-tumor immune response, could serve eventually as a model of immunotherapy against animal and human tumors.


Assuntos
Humanos , Animais , Camundongos , Anti-Inflamatórios/uso terapêutico , Vacinas Anticâncer/uso terapêutico , Células Dendríticas/imunologia , Dexametasona/uso terapêutico , Fibrossarcoma/tratamento farmacológico , Terapia de Imunossupressão/métodos , Sarcoma Experimental/tratamento farmacológico , Anti-Inflamatórios/imunologia , Vacinas Anticâncer/imunologia , Intervalo Livre de Doença , Dexametasona/imunologia , Fibrossarcoma/imunologia , Inflamação/tratamento farmacológico , Camundongos Endogâmicos BALB C , Metilcolantreno/efeitos adversos , Sarcoma Experimental/imunologia
10.
Medicina (B.Aires) ; 67(1): 44-48, jan.-fev. 2007. graf
Artigo em Espanhol | BINACIS | ID: bin-123134

RESUMO

Aunque existen vacunas para prevenir la aparición de tumores en animales de experimentación, la mayoría de los intentos por aplicar aquellas vacunas con fines terapéuticos contra tumores establecidos no han sido exitosos. Para comprender la naturaleza de esta refractariedad, estudiamos un tumor de ratón fuertemente inmunogénico inducido por el carcinógeno químico metilcolantreno. En nuestro modelo, el inicio de esta refractariedad coincidió con el comienzo de un estado de inmunosupresión conocido como "eclipse inmunológico" caracterizado por una pérdida o bloqueo de la respuesta inmune antitumoral después que el tumor ha superado cierto tamaño crítico. Este eclipse inmunológico fue acompañado por un proceso de inflamación sistémica en el organismo. El tratamiento de los ratones portadores de tumor con una única dosis del corticoide sintético dexametasona (DX) redujo los parámetros de inflamación sistémica e indujo la reversión del eclipse. Esta reversión no fue por sí misma curativa pero permitió que un tratamiento inmunológico basado en células dendríticas estimuladas con antígenos tumorales, que por sí solo era absolutamente ineficaz, pudiera ejercer un significativo efecto inhibidor sobre un tumor en crecimiento. El esquema de dos pasos que comprende, primero, un tratamiento antiinflamatorio para revertir el eclipse y segundo, una estrategia de vacunación basada en células dendríticas destinada a estimular la respuesta inmune antitumoral, podría servir, eventualmente, como un modelo de inmunoterapia contra tumores en animales y seres humanos.(AU)


Although animals can be prophylactically immunized against the growth of tumor implants, most of the attempts to use immunotherapy to cause the regression of animal and human tumors once they become established have been unsuccessful. To understand the nature of this refractoriness we have studied a methylcholanthrene-induced and strongly immunogenic murine fibrosarcoma. In our model, the onset of this refractoriness was associated with the beginning of an immunosuppressive state known as "immunological eclipse" characterized by a loss of the antitumor immune response when tumor grows beyond a critical size. This immunological eclipse was accompanied by the emergence of a systemic inflammatory condition. Treatment of tumor-bearing mice with a single dose of a synthetic corticosteroid, dexamethasone (DX), reduced significantly all parameters of systemic inflammation and simultaneously reversed the immunological eclipse. The reversion of the eclipse upon DX treatment was not curative itself, but allowed an immunological therapy based in dendritic cells pulsed with tumor antigens, which was itself absolutely ineffective, to exert a significant inhibitory effect against an established growing tumor. The two-step schedule using an anti-inflammatory treatment to reverse the immunological eclipse plus a dendritic cell-based vaccination strategy aimed to stimulate the anti-tumor immune response, could serve eventually as a model of immunotherapy against animal and human tumors. (AU)


Assuntos
Humanos , Animais , Camundongos , Vacinas Anticâncer/uso terapêutico , Fibrossarcoma/tratamento farmacológico , Sarcoma Experimental/tratamento farmacológico , Terapia de Imunossupressão/métodos , Células Dendríticas/imunologia , Dexametasona/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Vacinas Anticâncer/imunologia , Fibrossarcoma/imunologia , Sarcoma Experimental/imunologia , Dexametasona/imunologia , Anti-Inflamatórios/imunologia , Camundongos Endogâmicos BALB C , Metilcolantreno/efeitos adversos , Inflamação/tratamento farmacológico , Intervalo Livre de Doença
11.
Proc Natl Acad Sci U S A ; 101(29): 10721-5, 2004 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-15249662

RESUMO

Using the carcinogen 3-methylcholanthrene (MCA), we demonstrate with Fourier transform-infrared spectroscopy that a cancer DNA phenotype is produced well in advance of palpable tumors. We further demonstrate that the administration of cyclophosphamide markedly inhibits the development of the cancer phenotype and concomitantly delays tumor formation. MCA, injected into the hind legs of mice, produced a variety of significant structural changes in the nucleotide bases and phosphodiester-deoxyribose backbone, as reflected in a substantial (34%) difference between the mean DNA spectra of the control and the MCA-injected mice. Strikingly, 57 days before the mean appearance of tumors, we could not distinguish the DNA structure of the histologically normal tissues of the MCA-injected mice from the DNA structure of the tumor tissues. This finding indicates the early development of a cancer phenotype. Confirmatory evidence was obtained when tissues from a group of mice injected with both MCA and cyclophosphamide did not manifest the cancer phenotype, and their mean DNA structure closely resembled that of the control mice. Accordingly, we propose that the cancer DNA phenotype, as evinced by Fourier transform-infrared spectroscopy, is a promising early indicator of tumor formation, and we postulate that agents capable of inhibiting this phenotype may delay or prevent carcinogenesis.


Assuntos
DNA/química , Metilcolantreno/administração & dosagem , Neoplasias/genética , Fenótipo , Animais , Antineoplásicos Alquilantes/administração & dosagem , Ciclofosfamida/administração & dosagem , DNA/metabolismo , Feminino , Metilcolantreno/efeitos adversos , Camundongos , Camundongos Endogâmicos BALB C , Músculo Esquelético/citologia , Músculo Esquelético/patologia , Neoplasias/metabolismo , Neoplasias/patologia , Espectroscopia de Infravermelho com Transformada de Fourier
12.
Aquat Toxicol ; 63(2): 173-86, 2003 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-12657491

RESUMO

Several defence mechanisms, such as cytochrome P450 1A (CYP1A) enzymes and P-glycoprotein (Pgp), may influence the intracellular concentration and consequently the toxicity of xenobiotics. The parallel expression of CYP1A and Pgp has been investigated in mammals and, to a lesser extent in fish, in search for evidence of co-ordinated responses to xenobiotic exposure. The aryl hydrocarbon receptor (AHR) agonists are well known CYP1A inducers but some of them resulted not to have a uniquely defined action on Pgp levels in mammalian and fish species. To the best of our knowledge, no detailed studies have been carried out so far on amphibians Xenopus laevis. For this reason, in this work, the time dependent responses of the hepatic CYP1A and Pgp, to the prototypical CYP1A inducers, benzo(a)pyrene (B(a)P), 3-methylcholanthrene (3MC) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in X. laevis have been assessed at the protein level and compared. The responsiveness of Xenopus intestinal Pgp to these compounds has also been analysed, as the epithelial cells lining the lumen of intestine represent another preferential site of Pgp expression. In addition, since the thyroid hormone has been demonstrated to down regulate the mdr gene during Xenopus development and in primary culture of Xenopus intestinal epithelial cells, the effects of 3,3',5-triiodo-L-thyronine (T(3)) on CYP1A and Pgp protein levels have been investigated in adult organisms. Western blot evidenced that a single injection of B(a)P (100 mg/kg), 3MC (20 mg/kg), and TCDD (3 microg/kg) elicited a statistically significant induction of hepatic CYP1A at all time points considered (72, 120 and 168 h) which decreased in time. The same trend of liver CYP1A induction was observed in T(3) treated Xenopus (15 microg/kg). Unlike CYP1A induction, the modulation of hepatic and intestinal Pgp expression exhibits an heterogeneous pattern. The basal levels of hepatic and intestinal Pgp were not statistically significant affected by treatments. In particular, the hepatic Pgp levels seem not to be induced by TCDD and T(3) at all times considered in comparison to control. For the first time the modulation of CYP1A and Pgp levels by B(a)P, 3MC and in particular by TCDD and T(3) in Xenopus has been demonstrated and the results herewith indicate that the two target defence mechanisms respond to AHR agonists in a dissimilar way in terms of proteins induction in Xenopus. Moreover, these data suggest additional experiments in order to clarify the complex mechanism, which adjusts the parallel expression of CYP1A and Pgp in Xenopus.


Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/biossíntese , Benzo(a)pireno/efeitos adversos , Carcinógenos/efeitos adversos , Citocromo P-450 CYP1A1/biossíntese , Poluentes Ambientais/efeitos adversos , Metilcolantreno/efeitos adversos , Dibenzodioxinas Policloradas/efeitos adversos , Animais , Western Blotting , Fenômenos Fisiológicos do Sistema Digestório , Fígado/fisiologia , Receptores de Hidrocarboneto Arílico/agonistas , Xenopus laevis
13.
Gig Sanit ; (5): 67-9, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12476844

RESUMO

Experiments on 892 non-inbred male rats studied the development of renal tumors in the animals intermittently administered two substances different in the mechanism of carcinogenic action. Renal pre-injection of methylcholantherene (MC) in a small dose insufficient to induce renal tumors in the study period, followed by dermal applications of this agent was shown to enhance a blastomogenic effect, as manifested by both early occurrence of precarcinogenic changes and early development of renal tumors at the site of primary injection of MC into the kidney. The effect of nitrosodimethylamine (NDMA) intermittently injected in a nephrotropic dose was studied in the second series of the experiments. The intermittent injection of NDMA in courses during 8 weeks gave rise to renal tumors in the early period, caused increases in the number of tumors and in the area of renal tumor proliferates. The mechanism of enhanced renal blastomogenesis is discussed in terms of the mechanisms responsible for initiation and progression.


Assuntos
Dimetilnitrosamina/efeitos adversos , Neoplasias Renais/induzido quimicamente , Metilcolantreno/efeitos adversos , Animais , Dimetilnitrosamina/administração & dosagem , Injeções , Metilcolantreno/administração & dosagem , Periodicidade , Ratos
14.
Zhonghua Zhong Liu Za Zhi ; 24(4): 316-9, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12408753

RESUMO

OBJECTIVE: To investigate the expression of two inflammation related enzymes - cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) during the experimental rat lung carcinogenesis. METHODS: Eighty Wistar rats were instilled with 3-methylcholanthrene (MCA) and diethylinitrosamine (DEN) into the left lobar branchus to induce lung squamous cell carcinoma. To obtain specimen in every pathological phase during the carcinogenesis, these rats were sacrificed at different intervals. The expression of COX-2 and iNOS in every pathological phase during the carcinogenesis were examined by immunohistochemical method. The immunohistochemical scores (IHS) were calculated by combining an estimate of the percentage of immunoreactive cells with that of the stain intensity. RESULTS: 155 specimens of every pathological phase during the carcinogenesis showed: hyperplasia 14, squamous metaplasia 25, dysplasia 33, carcinoma in situ 12, infiltrating carcinoma 54 and metastasis 17. Inflammation and elevated expressions of COX-2 and iNOS were shown in the precancerous lesions. The COX-2 IHS was significantly increased in dysplasia, carcinoma in situ and metastasis (P < 0.01, P < 0.05, P < 0.01 respectively). The iNOS IHS significantly increased in hyperplasia and metastasis (P < 0.05, P < 0.01 respectively). There was a positive correlation between the expression of COX-2 and iNOS (gamma = 0.601 6, P < 0.001). CONCLUSION: COX-2 and iNOS, two inflammation related enzymes, playing important roles in the carcinogenesis of MCA and DEN, induce rat lung squamous cell carcinoma as well as its metastasis. The relation between inflammation and carcinogenesis may partly be explained by the elevated expression of these two enzymes. Nonsteroidal antiinflammatory drug (COX-2 inhibitors) and iNOS inhibitors may possess antitumor activities because of their prevention of bronchial dysplasia, carcinogenesis and metastasis.


Assuntos
Carcinoma de Células Escamosas/enzimologia , Isoenzimas/biossíntese , Neoplasias Pulmonares/enzimologia , Óxido Nítrico Sintase/biossíntese , Prostaglandina-Endoperóxido Sintases/biossíntese , Animais , Carcinógenos/efeitos adversos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/patologia , Ciclo-Oxigenase 2 , Feminino , Imuno-Histoquímica/métodos , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/patologia , Masculino , Metilcolantreno/efeitos adversos , Neoplasias Experimentais/induzido quimicamente , Neoplasias Experimentais/enzimologia , Neoplasias Experimentais/patologia , Óxido Nítrico Sintase Tipo II , Ratos , Ratos Wistar
16.
Toxicol In Vitro ; 16(4): 365-74, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12110274

RESUMO

The rainbow trout cytochrome P4501A gene subfamily consists of two members, CYP1A1 and CYP1A3, which are induced by polycyclic aromatic hydrocarbons (PAHs). In this study, we investigated the induction of cytochrome P4501A3 in the rainbow trout (Onchorhynchus mykiss) D-11 cell line after 3-methylcholanthrene (3MC) exposure by generating chimeric constructs in which a 2.3 kb fragment or portion of the 5'-flanking region of the trout cytochrome CYP1A3 gene was fused to the firefly luciferase (Luc) gene. The constructs were then transiently transfected into the trout D-11 cells and their transcriptional activity measured by luciferase assay after treatment with different 3MC concentrations. Maximal induction following exposure to 2 microM 3MC was 2.2-fold after 72 h. Deletion of the region specifying the 5' untranslated region (5'UTR) of the mRNA encoding the CYP1A3 gene increased unstimulated luciferase activity but also led to a loss of response to 3MC treatment. This finding suggests that the region specifying the 5'UTR contains a negative element that is also involved in the transcriptional response to 3MC.


Assuntos
Hidrocarboneto de Aril Hidroxilases/farmacologia , Oncorhynchus mykiss/fisiologia , Animais , Hidrocarboneto de Aril Hidroxilases/genética , Sequência de Bases , Carcinógenos/efeitos adversos , Linhagem Celular , Fibroblastos/patologia , Luciferases/farmacologia , Metilcolantreno/efeitos adversos , Dados de Sequência Molecular , RNA Mensageiro , Transfecção
17.
J Pharm Pharmacol ; 53(5): 763-8, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11370717

RESUMO

Berberine, an alkaloid isolated from the plant Berberis aristata, has been found to inhibit significantly the carcinogenesis induced by 20-methylcholanthrene (200 microg/0.1 mL/mouse) or N-nitrosodiethylamine (NDEA; 0.02% NDEA in distilled water, 2.5 mL/animal by gavage, five days a week for 20 weeks) in a dose-dependent manner in small animals. Administration of berberine (0.5, 2.5 or 5.0 mg kg(-1)) could reduce significantly the incidence of tumour in animals after an injection of 20-methylcholanthrene and increased their life span compared with the control. When berberine (10, 25 or 50 mg kg(-1)) was administered simultaneously with NDEA, the markers of liver injury (liver weight, gamma-glutamyl transpeptidase activity and glutathione S-transferase level) were reduced significantly compared with animals treated with NDEA only, which resulted in all the values being elevated. A similar decrease was noted in the serum levels of lipid peroxide, bilirubin and glutamate pyruvate transaminase. Morphology of liver tissue and levels of marker enzymes indicated that berberine offered protection against chemical carcinogenesis.


Assuntos
Berberina/farmacologia , Transformação Celular Neoplásica , Neoplasias Hepáticas/prevenção & controle , Fígado/efeitos dos fármacos , Sarcoma/prevenção & controle , Alquilantes/administração & dosagem , Alquilantes/efeitos adversos , Animais , Dietilnitrosamina/administração & dosagem , Dietilnitrosamina/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Peroxidação de Lipídeos , Fígado/patologia , Neoplasias Hepáticas/fisiopatologia , Metilcolantreno/administração & dosagem , Metilcolantreno/efeitos adversos , Camundongos , Neoplasias Experimentais , Extratos Vegetais/farmacologia , Ratos , Ratos Wistar , Sarcoma/fisiopatologia
18.
Cancer Immun ; 1: 7, 2001 Apr 27.
Artigo em Inglês | MEDLINE | ID: mdl-12747768

RESUMO

Immunotherapy with gp96 was highly effective in mice bearing methylcholanthrene-induced fibrosarcomas (Meth A tumors) when treatment began 7 days or less after tumor challenge, but significantly less effective if the treatment began 9 days after challenge. Immunotherapy of pre-existing tumors showed all the hallmarks of specificity of gp96 and dose-restriction observed previously with prophylactic studies. When mice with large primary Meth A tumors were treated with surgery alone, or with surgery followed by therapy with Meth A-derived gp96, the mice that received surgery and immunotherapy did significantly better than those receiving surgery alone. The relationship between the time of initiation of immunotherapy with gp96 and its efficacy was also tested in a metastatic model of the Lewis lung carcinoma. In this model, immunotherapy with gp96 was very effective if treatment began up to 31 days after tumor challenge, but significantly less so if therapy was initiated day 33 post-tumor challenge. These observations suggest that the regulatory phenomena that interfere with immunotherapy gather momentum with surprising speed.


Assuntos
Antígenos de Neoplasias/uso terapêutico , Proteínas de Choque Térmico/uso terapêutico , Imunoterapia/métodos , Adjuvantes Imunológicos/uso terapêutico , Animais , Antígenos de Neoplasias/administração & dosagem , Antígenos de Superfície/administração & dosagem , Antígenos de Superfície/uso terapêutico , Carcinoma Pulmonar de Lewis/química , Carcinoma Pulmonar de Lewis/secundário , Carcinoma Pulmonar de Lewis/cirurgia , Carcinoma Pulmonar de Lewis/terapia , Terapia Combinada/métodos , Fibrossarcoma/induzido quimicamente , Fibrossarcoma/cirurgia , Fibrossarcoma/terapia , Proteínas de Choque Térmico/administração & dosagem , Injeções Intradérmicas , Metilcolantreno/efeitos adversos , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Transplante de Neoplasias , Indução de Remissão , Fatores de Tempo
19.
Eur J Histochem ; 45(4): 319-32, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11846000

RESUMO

We examined the clonal evolution of skin malignant lesions by repeated topical applications of 20-methylcholanthrene (20-MC) to the skin, which induces hyperplastic epidermis, papillomatous lesion and invasive carcinoma in mice. The lesions were examined histologically and immunohistochemically with anti-single-stranded DNA after acid hydrolysis (DNA-instability test), p53, VEGF, DFF45, PCNA and AgNORs parameters analyses. Multiple clones with increased DNA instability comparable to that of invasive carcinoma were noted in early-stage (2-6 weeks) hyperplastic epidermis, and their number increased in middle (7-11 weeks), and late-stages (12-25 weeks) of hyperplastic epidermis, indicating that they belong to the malignancy category. All papillomatous lesions and invasive carcinomas showed a positive DNA-instability test. Positive immunostaining for various biomarkers and AgNORs parameters appeared in clones with a positive DNA-instability test in early-or middle-stage hyperplastic epidermis, and markedly increased in late-stage hyperplastic epidermis, papillomatous lesions and invasive carcinomas. The percentage of PCNA-positive vascular endothelial cells was significantly higher in VEGF-positive lesions with a positive DNA-instability test and became higher toward the late-stage of progression. Cut-woundings were made to papillomatous and invasive carcinoma lesions, and the regeneration activity of vascular endothelial cells was determined by using flash labeling with tritiated thymidine (3H-TdR). In small papillomatous lesions, vascular endothelial cells showed regenerative response, but the response was weak in large lesions. No such response was noted in invasive carcinomas; rather, cut-wounding induced collapse of blood vessels, which in turn induced massive coagulative necrosis of cancer cells. These responses can be interpreted to reflect exhausted vascular growth activity due to excessive stimulation by VEGF-overexpression, which was persistently seen from hyperplastic epidermis to invasive carcinoma.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma de Células Escamosas/química , DNA de Neoplasias/análise , Neoplasias Cutâneas/química , Animais , Antígenos CD34/análise , Proteínas Reguladoras de Apoptose , Carcinógenos/efeitos adversos , Carcinoma de Células Escamosas/induzido quimicamente , Carcinoma de Células Escamosas/patologia , Modelos Animais de Doenças , Fatores de Crescimento Endotelial/análise , Imuno-Histoquímica/métodos , Linfocinas/análise , Masculino , Metilcolantreno/efeitos adversos , Camundongos , Antígeno Nuclear de Célula em Proliferação/análise , Proteínas/análise , Neoplasias Cutâneas/induzido quimicamente , Neoplasias Cutâneas/patologia , Coloração e Rotulagem/métodos , Proteína Supressora de Tumor p53/análise , Fator A de Crescimento do Endotélio Vascular , Fatores de Crescimento do Endotélio Vascular
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...